New Drug Approvals

<< Drug Pipeline Review

Last updated: 05.26.21

Date Drug Manufacturer Use Specialty
Jan. 20 Verquvo (vericiguat) Merck & Co. Heart Failure  
Jan. 21 Vocabria (cabotegravir) ViiV Healthcare HIV S
Jan. 21 Cabenuva (cabotegravir and rilpivirine extended-release injection) ViiV Healthcare HIV S
Jan. 22 Lupkynis (voclosporin)  Aurinia Lupus Nephritis S
Feb. 03 Tepmetko (tepotinib) EMD Serono Non‐Small Cell Lung Cancer S
Feb. 05 Ukoniq (umbralisib) TG Therapeutics Marginal Zone Lymphoma S
Feb. 05 Breyanzi (lisocabtagene maraleucel) BMS Non‐Hodgkin's Lymphoma S
Feb. 11 Evkeeza (evinacumab) Regeneron Homozygous Familial Hypercholesterolemia S
Feb. 15 Cosela (trilaciclib) G1 /BI Small Cell Lung Cancer S
Feb. 25 Amondys 45 (casimersen) Sarepta Duchenne Muscular Dystrophy S
Mar. 01 Pepaxto (melphalan flufenamide) Oncopeptides Multiple Myeloma S
Mar. 01 Nulibry (fosdenopterin) Alexion/BridgeBio Molybdenum Cofactor Deficiency (MoCD) Type A S
Mar. 02 Azstarys (serdexmethylphenidate/dexmethylphenidate) KemPharm ADHD  
Mar. 11 Fotivda (tivozanib) Aveo Renal Cell Carcinoma S
Mar. 18 Ponvory (ponesimod)  Janssen Relapsing Multiple Sclerosis S
Mar. 12 Kimyrsa (oritavancin) Melinta Therapeutics IV Antibiotic  
Mar. 22 Zegalogue (dasiglucagon) Zealand Pharma  Hypoglycemia  
Mar. 26 Abecma® (idecabtagene vicleucel)  Bristol Myers Squibb/bluebird bio Multiple Myeloma S

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, review your plan documents or contact a Cigna representative.

All Cigna products and service are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Evernorth, Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.

© 2021 Cigna. All rights reserved